Pre-made Fasinumab benchmark antibody ( Whole mAb, anti-NGFB/NGF therapeutic antibody, Anti-HSAN5 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-206

Pre-Made Fasinumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-206-1mg 1mg 3090
GMP-Bios-ab-206-10mg 10mg Inquiry
GMP-Bios-ab-206-100mg 100mg Inquiry
GMP-Bios-ab-206-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Fasinumab biosimilar, Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody
INN Name Fasinumab
TargetNGF
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2012
Year Recommended2013
CompaniesMitsubishi Tanabe Pharma Corporation;Regeneron Pharmaceuticals;Teva Pharmaceutical Industries;Sanofi
Conditions Approvedna
Conditions ActiveBack pain;Pain
Conditions Discontinuedna
Development TechVelocImmune Mouse